QUICK CONVENIENT PRECISE DISCREET Trademark

Trademark Overview


On Friday, June 29, 2018, a trademark application was filed for QUICK CONVENIENT PRECISE DISCREET with the United States Patent and Trademark Office. The USPTO has given the QUICK CONVENIENT PRECISE DISCREET trademark a serial number of 88021002. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 28, 2020. This trademark is owned by Rapid Dose Therapeutics Inc.. The QUICK CONVENIENT PRECISE DISCREET trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Orally dissolvable films containing nutraceuticals, namely, biotin, folic acid, resveratrol, DHEA, NAD, curcumin; orally dissolvable films containing, vitamins, caffeine, melatonin, and herbal supplements for general health and well-being, dietary supplements for general health and well-being, nicotine and nicotine-polymer complexes; orally dissolvable films containing non-prescription pharmaceutical preparations sold over-the-counter for the relief of pain, cough, cold, flu, allergy symptoms, cardiac health, nicotine smoking cessation, anti-gas for stomach bloating, anemia, and to promote wound healing; orally dissolvable films containing prescription pharmaceutical preparations indicated for the relief of nausea, vomiting, hyperglycemia, diabetes, erectile dysfunction, anti-anxiety, anti-depressant, migraine headache pain, anemia, cardiac health, angina, hypertension, and to reverse and prevent opioid overdose; orally dissolvable films containing human vaccine and human biologic medi...

Consulting in the healthcare field regarding orally dissolvable films containing nutraceuticals, namely, biotin, folic acid, resveratrol, DHEA, NAD, curcumin; consulting in the healthcare field related to orally dissolvable films containing, vitamins, caffeine, melatonin, herbal supplements for general health and well-being, dietary supplements for general health and well-being, nicotine and nicotine-polymer complexes; consulting in the healthcare field related to orally dissolvable films containing non-prescription pharmaceutical preparations sold over-the-counter for the relief of pain, cough, cold, flu, allergy symptoms, cardiac health, nicotine smoking cessation, anti-gas for stomach bloating, anemia, and to promote wound healing; consulting in the healthcare field related to orally dissolvable films containing prescription pharmaceutical preparations indicated for the relief of nausea, vomiting, hyperglycemia, diabetes, erectile dysfunction, anti-anxiety, anti-depressant, migraine...
quick convenient precise discreet

General Information


Serial Number88021002
Word MarkQUICK CONVENIENT PRECISE DISCREET
Filing DateFriday, June 29, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 28, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2019

Trademark Statements


Goods and ServicesOrally dissolvable films containing nutraceuticals, namely, biotin, folic acid, resveratrol, DHEA, NAD, curcumin; orally dissolvable films containing, vitamins, caffeine, melatonin, and herbal supplements for general health and well-being, dietary supplements for general health and well-being, nicotine and nicotine-polymer complexes; orally dissolvable films containing non-prescription pharmaceutical preparations sold over-the-counter for the relief of pain, cough, cold, flu, allergy symptoms, cardiac health, nicotine smoking cessation, anti-gas for stomach bloating, anemia, and to promote wound healing; orally dissolvable films containing prescription pharmaceutical preparations indicated for the relief of nausea, vomiting, hyperglycemia, diabetes, erectile dysfunction, anti-anxiety, anti-depressant, migraine headache pain, anemia, cardiac health, angina, hypertension, and to reverse and prevent opioid overdose; orally dissolvable films containing human vaccine and human biologic medications which function as biologic response modifiers in the human immune system for the treatment and prevention of influenza, auto-immune disease syndrome (AIDS), HIV infections, inflammatory bowel disease, Crohn's Disease, Ulcerative Colitis, rheumatoid arthritis, diabetes, insulinemia, psoriasis, herpes, HPV prevention, polio, tuberculosis, hepatitis, diphtheria, typhoid, meningitis, multiple sclerosis, lupus, Varicella viral infections (chicken pox), West Nile Virus infections, H1N1 flu infections, cancer, and age-related Macular Degeneration; none of the foregoing comprised of Cannabis sativa based ingredients
Goods and ServicesConsulting in the healthcare field regarding orally dissolvable films containing nutraceuticals, namely, biotin, folic acid, resveratrol, DHEA, NAD, curcumin; consulting in the healthcare field related to orally dissolvable films containing, vitamins, caffeine, melatonin, herbal supplements for general health and well-being, dietary supplements for general health and well-being, nicotine and nicotine-polymer complexes; consulting in the healthcare field related to orally dissolvable films containing non-prescription pharmaceutical preparations sold over-the-counter for the relief of pain, cough, cold, flu, allergy symptoms, cardiac health, nicotine smoking cessation, anti-gas for stomach bloating, anemia, and to promote wound healing; consulting in the healthcare field related to orally dissolvable films containing prescription pharmaceutical preparations indicated for the relief of nausea, vomiting, hyperglycemia, diabetes, erectile dysfunction, anti-anxiety, anti-depressant, migraine headache pain, anemia, cardiac health, angina, hypertension, and to reverse and prevent opioid overdose; consulting in the healthcare field related to orally dissolvable films containing human vaccine and human biologic medications which function as biologic response modifiers in the human immune system for the treatment and prevention of influenza, auto-immune disease syndrome (AIDS), HIV infections, inflammatory bowel disease, Crohn's Disease, Ulcerative Colitis, rheumatoid arthritis, diabetes, insulinemia, psoriasis, herpes, HPV prevention, polio, tuberculosis, hepatitis, diphtheria, typhoid, meningitis, multiple sclerosis, lupus, Varicella viral infections (chicken pox), West Nile Virus infections, H1N1 flu infections, cancer, and age-related Macular Degeneration

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 6, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 26, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRapid Dose Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurlington, Ontario L7N2G4
CA

Party NameRapid Dose Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, Ontario L7N2G4
CA

Trademark Events


Event DateEvent Description
Monday, September 28, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 28, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 31, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 15, 2019EXAMINER'S AMENDMENT ENTERED
Friday, November 15, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 15, 2019EXAMINERS AMENDMENT E-MAILED
Friday, November 15, 2019EXAMINERS AMENDMENT -WRITTEN
Saturday, October 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, October 26, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 23, 2019ASSIGNED TO LIE
Friday, October 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 5, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 5, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 19, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 18, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 18, 2019NON-FINAL ACTION E-MAILED
Thursday, April 18, 2019NON-FINAL ACTION WRITTEN
Wednesday, April 10, 2019ASSIGNED TO EXAMINER
Friday, September 28, 2018ASSIGNED TO EXAMINER
Tuesday, September 25, 2018ASSIGNED TO EXAMINER
Friday, July 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM